Novel receptor surface approach for 3D-QSAR: The weighted probe interaction energy method

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 5, 2004, Pages 1774-1787

  Chae, Chong Hak ^a,b   Yoo, Sung Eun ^b   Shin, Whanchul ^a  

^a Seoul National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; ENZYME INHIBITION; GENETIC ALGORITHMS; HYDROGEN BONDS; LEAST SQUARES APPROXIMATIONS; MOLECULAR STRUCTURE; NEURAL NETWORKS; SOLVENTS;

DRUG DESIGN; ELECTROSTATIC POTENTIAL; LIGANDS;

SURFACE CHEMISTRY;

EID: 5444265194     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci0498721     Document Type: Article

References (50)

1. Kubinyi, H. 3D QSAR in Drug Design; Theory, Methods and Applications; ESCOM: Leiden, 1993.
2. Platt, D. E.; Parida, L.; Gao, Y.; Floratos, A.; Rigoutsos, I. QSAR in grossly underdetermined systems: Opportunities and issues, IBM J. Res. Dev. 2001, 45, 533-544.
3. Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
4. Kubinyi, H. Comparative molecular field analysis (CoMFA). In The Encyclopedia of Computational Chemistry; Schleyer, P. v. R., Allinger, N. L., Clark, T., Gasteiger, J., Kollman, P. A., Schaefer, H. F., III, Schreiner, P. R. Eds.; John Wiley & Sons: Chichester, 1998; pp 448-460.
5. Norinder, U. Recent progress in CoMFA methodology and related techniques. In 3D QSAR in Drug Design. Volume 2. Ligand-Protein Interactions and Molecular Similarity; Kubinyi, H., Folkers, G., Martin, Y. C. Eds.; Kluwer/ESCOM: Dordrecht, 1998; pp 25-39.
6. Bush, B. L.; Nachbar, R. B. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J. Comput.-Aided Mol. Des. 1993, 7, 587-619.
7. Cruciani, G.; Watson, K. A. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. J. Med. Chem. 1994, 37, 2589-2601.
8. 2-guided region selection for comparative molecular field analysis; A simple method to achieve consistent results. J. Med. Chem. 1995, 38, 1060-1066.
9. Hopfinger, A. J.; Wang, S.; Tokarski, J. S.; Jin, B. Q.; Albuquerque, M.; Madhav, P. J.; Duraiswami, C. Construction of 3D-QSAR models using 4D-QSAR analysis formalism. J. Am. Chem. Soc. 1997, 119, 10509-10524.
10. Pastor, M.; Cruciani, G.; Clementi, S. Smart region definition (SRD): A new way to improve the predictive ability and interpretability of 3D-QSAR models. J. Med. Chem. 1997, 40, 1455-1464.
11. Wold, S.; Johansson, E.; Cocci, M. PLS-partial least squares projection to latent structures. In 3D QSAR in Drug Design; Kubinyi, H. Ed.; ESCOM: Leiden, 1993; pp 523-563.
12. Kim, K. H.; Greco, G.; Novellino, E.; Silipo, C.; Vittoria, A. Use of the hydrogen bond potential function in a comparative molecular field analysis (CoMFA) on a set of benzodiazepines. J. Comput.-Aided Mol. Des. 1993, 7, 263-280.
13. Leo, A. J.; Hansch, C. Role of hydrophobic effects in mechanistic QSAR. J. Comput.-Aid. Mol. Des. 1999, 17, 1-25.
14. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4146.
15. +/peptide cotransporter PEPT1. J. Med. Chem. 2003, 46, 5725-5734.
16. 4 receptor antagonists. J. Chem. Inf. Comput. Sci. 2003, 43, 1020-1027.
17. Kuo, C.-L.; Assefa, H.; Kamath, S.; Brzozowski, Z.; Slawinski, J.; Saczewski, F.; Buolamwini, J. K.; Neamati, N. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors. J. Med. Chem. 2004, 47, 385-399.
18. Kubinyi, H.; Hamprecht, F. A.; Mietzner, T. Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. J. Med. Chem. 1998, 41, 2553-2564.
19. So, S.-S.; Karplus, M. Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations. J. Med. Chem. 1997, 40, 4347-4359.
20. So, S.-S.; Karplus, M. Three-dimensional quantitative structure activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications. J. Med. Chem. 1997, 40, 4360-4371.
21. Doweyko, A. M. The hypothetical active site lattice. An approach to modelling active site from data on inhibitor molecules. J. Med. Chem. 1988, 31, 1396-1406.
22. Robinson, D. D.; Winn, P. J.; Lyne, P. D.; Richards, W. G. self-organizing molecular field analysis: A tool for structure-activity studies. J. Med. Chem. 1999, 42, 573-583.
23. Jain, A. N.; Koile, K.; Chapman, D. Compass: Predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. J. Med. Chem. 1994, 37, 2315-2327.
24. Wagener, M.; Sadowski, J.; Gasteiger, J. Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J. Am. Chem. Soc. 1995, 117, 7769-7775.
25. Bravi, G.; Gancia, E.; Mascagni, P.; Pegna, M.; Todeschini, R.; Zaliani, A. MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids. J. Comput.-Aided Mol. Des. 1997, 11, 79-92.
26. Pastor, M.; Cruciani, G.; McLay, I.; Pickett, S.; Clementi, S. GRid-INdependent Descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. J. Med. Chem. 2000, 43, 3233-3243.
27. Polanski, J.; Gieleciak, R.; Bak, A. The comparative molecular surface analysis (COMSA) - A nongrid 3D QSAR method by a coupled neural network and PLS system: Predicting pKa values of benzolc and alkanoic acids. J. Chem. Inf. Comput. Sci. 2002, 42, 184-191.
28. Hahn, M. Receptor surface models. 1. Definition and construction. J. Med. Chem. 1995, 38, 2080-2090.
29. Hahn, M.; Rogers, D. Receptor surface models. 2. Application to quantitative structure-activity relationships studies. J. Med. Chem. 1995, 38, 2091-2102.
30. Walters, D. E.; Hinds, R. M. Genetically evolved receptor models (GERM): A computational approach to construction of receptor models. J. Med. Chem. 1994, 37, 2527-2536.
31. Chen, H.; Zhou, J.; Xie, G. PARM: A genetic evolved algorithm to predict bioactivity. J. Chem. Inf. Comput. Sci. 1998, 38, 243-250.
32. Pei, J.; Zhou, J.; Xie, G.; Chen, H.; He, X. FARM: A practical utility for drug design. J. Mol. Graph. Model. 2001, 19, 448-454.
33. Pei, J.; Zhou, J.; Xie, G.; Chen, H.; He, X. Flexible atom receptor model (FLARM). Acta Chim. Sinica 2002, 60, 973-979.
34. Peng, T.; Pei, J.; Zhou, J. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM). J. Chem. Inf. Comput. Sci. 2003, 43, 298-303.
35. Vedani, A.; Dobler, M.; Zbinden, P. Quasi-atomistic receptor surface models: A bridge between 3-D QSAR and receptor modeling. J. Am. Chem. Soc. 1998, 120, 4471-4477.
36. Vedani, A.; Briem, H.; Dobler, M.; Dollinger, H.; McMasters, D. R. Multiple-conformation and protonation-state representation in 4D-QSAR: The neurokinin-1 receptor system. J. Med. Chem. 2000, 43, 4416-4427.
37. Vedani, A.; Dobler, M. 5D-QSAR: The key for simulating induced fit? J. Med. Chem. 2002, 45, 2139-2149.
38. Ortiz, A. R.; Pisabarro, M. T.; Gago, F.; Wade, R. C. Prediction of drug binding affinities by comparative binding energy analysis. J. Med. Chem. 1995, 38, 2681-2691.
39. Wang, T.; Wade, R. C. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. J. Med. Chem. 2001, 44, 961-971.
40. Lorensen, W. E.; Cline, H. E. Marching cubes: A high resolution 3D surface construction algorithm. Computer Graphics 1987, 21, 163-169.
41. Heiden, W.; Goetze, T.; Brickmann, J. Fast generation of molecular surfaces from 3D data fields with an enhanced "marching cube" algorithm. J. Comput. Chem. 1993, 14, 246-250.
42. Gasteiger, H.; Marsili, M. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron 1980, 36, 3219-3288.
43. Shin, W.; Oh, D.-G.; Chae, C. H.; Yoon, T. S. Conformational analysis of thiamin-related compounds: A stereochemical model for thiamin catalysis. J. Am. Chem. Soc. 1993, 115, 12238-12250.
44. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Salvatore, P., Jr.; Weiner, P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 1984, 106, 765-784.
45. Judson, R. Genetic algorithms and their use in chemistry. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: New York, 1997; pp 1-73.
46. Kubinyi, H.; Abraham, U. Practical problems in PLS analysis. In 3D QSAR in Drug Design; Theory, Methods and Applications; Kubinyi, H. Ed.; ESCOM: Leiden, 1993; pp 717-728.
47. Safe, S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 1990, 21, 51-88.
48. Coats, E. A. The CoMFA steroids as a benchmark dataset for development of 3D QSAR methods. In 3D QSAR in Drug Design. Volume 3. Recent Advances; Kubinyi, H., Folkers, G., Martin, Y. C., Eds.; Kluwer/ESCOM: Dordrecht, 1998; pp 199-213.
49. http://www2.ccc.uni-erlangen.de/services/steroids/index.html.
50. Davies, J. F., II.; Delcamp, T. J.; Prendergast, N. J.; Ashford, V. A.; Freisheim, J. H.; Kraut, J. Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. Biochemistry 1990, 29, 9467-9479.